Cerevast Therapeutics Garners $6,564,658 Series C Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dd01217d-1404-4cdd-95f3-10c25ed238c9&Preview=1 -
Date
12/13/2011 -
Company Name
Cerevast Therapeutics -
Mailing Address
12277 134th Court NE Redmond, WA 98052 -
Company Description
Cerevast Therapeutics, Inc. is a medical technology company with primary emphasis in the field of SonoLysis for the treatment acute ischemic stroke and other vascular disorders. -
Website
http://www.cerevast.com -
Transaction Type
Venture Equity -
Transaction Amount
$6,564,658 -
Transaction Round
Series C -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
